Work

Real-world outcomes of patients with relapsed refractory multiple myeloma treated with commercial bispecific T-cell engager antibodies: a single center experience

Year: 2025

Type: article

Study design: Observational Study

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2025.2592783

Authors: Lindsay Fogel, Patrick C. Roney, Jaeil Ahn, Adolfo Aleman, Fideliza Perez-Manon, Natalie Arias-Orozco, Gabriella Monteleone, Kiara Londono, Kathleen Builes, Palka Anand, Harsh Parmar, Pooja Phull, David Vesole, David S. Siegel, Andrew Ip, Noa Biran

Institutions: Hackensack Meridian School of Medicine, Georgetown University, Georgetown Lombardi Comprehensive Cancer Center, Hackensack University Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416906001

FWCI: 1.27

Cites: 33

Cited by: 2

Related to: